Screening of commercial compounds in drug discovery

パトコア

"Can even new drugs be discovered from commercially available compounds?" The size of the drug-like chemical space is estimated to be about 10^63 molecules. It is expected that future drugs will be found somewhere in this vast space. To enable chemists to easily access this chemical space, several compound vendors are building commercial databases of available compounds or drug-like compounds that are predicted to have a high likelihood of being synthesized. Many pharmaceutical companies are also building their own databases. ChemAxon provides access to various databases through its compound design platform "Design Hub," and we have compiled this information into a white paper, so please take a look.

Date and time
Capital
Entry fee

Related product information

Innovative drug discovery information platform 'Design Hub'
Design HUB is a groundbreaking information platform that integrates hypothesis-driven and data-driven approaches to streamline the DMTA cycle in drug discovery.

【Other Features】 <Integration of External Resources> ■ Customizable plugins based on JavaScript and a wealth of templates ■ Data integration with any service via REST, SQL, or CLI methods <Management of Ideas and Projects> ■ Organize and manage original data and discussion content by hypothesis ■ Save data used for analysis during the structural optimization phase as a design set ■ Visualize who is responsible for what and the progress status using a Kanban board *For more details, please refer to the PDF document or feel free to contact us.

Related catalog

Screening of commercial compounds in drug discovery

PRODUCT

Contact this catalog

Compound design platform "Design Hub" collaboration foundation

PRODUCT

Contact this catalog

Return to news list